World Journal of Dentistry

Register      Login

VOLUME 13 , ISSUE 6 ( November-December, 2022 ) > List of Articles


Antibiofilm Efficacy of Mimosa pudica against Clinical Isolates of Streptococcus mutans as a Mouthrinse

Baskar Kavya, NJ Nagaraj, Manavalan Madhana Madhubala, Sekar Mahalaxmi

Keywords : Biofilm, Chlorhexidine, Mimosa pudica L., Mouthrinse

Citation Information : Kavya B, Nagaraj N, Madhubala MM, Mahalaxmi S. Antibiofilm Efficacy of Mimosa pudica against Clinical Isolates of Streptococcus mutans as a Mouthrinse. World J Dent 2022; 13 (6):582-586.

DOI: 10.5005/jp-journals-10015-2097

License: CC BY-NC 4.0

Published Online: 26-08-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: The aim of this study was to comparatively evaluate the antibiofilm efficacy of Mimosa pudica L. and chlorhexidine (CHX) against Streptococcus mutans (S. mutans) as a mouthrinse. Methods: S. mutans were cultured from saliva collected from high caries risk patients and inoculated in Mueller–Hinton agar plates. The mouthrinses were grouped as follows: group I—10% aqueous extract of M. pudica L. mouthrinse, group II—0.2% CHX mouthrinse, and group III—saline. The resazurin-based dye microbroth assay was used to check the effect of test rinses on the redox activity of salivary bacteria and optical density (OD) values were recorded. Biofilm was grown on the surface of enamel slabs for 7 days in an anaerobic work station using S. mutans and treated with respective mouthrinses for 2 minutes at room temperature. The slabs were stained using fluorescent dye propidium iodide and SYTO9 and visualized under confocal scanning laser microscopy (CLSM) and qualitatively analyzed for live/dead bacteria. The percentage of viability was determined and statistically analyzed using the one-way analysis of variance (ANOVA) test at the p-value of <0.05. Results: Based on OD values of resazurin-based dye assay and CLSM analysis, group II showed higher antibacterial efficacy with significant differences than groups I and III. Conclusion: The percentage of biofilm inhibition was found to be less for aqueous extract of M. pudica L. than CHX. However, it is evident that M. pudica L. can resist the oral cariogenic bacteria, thereby preventing the formation of dental caries.

PDF Share
  1. Fejerskov. Changing paradigms in concepts on dental caries: consequences for oral health care. Caries Res 2004;38(3):182–191. DOI: 10.1159/000077753
  2. Mathur VP, Dhillon JK. Dental caries: a disease which needs attention. Indian J Pediatr 2018;85(3):202–206. DOI: 10.1007/s12098-017-2381-6
  3. Aas JA, Griffen AL, Dardis SR, et al. Bacteria of dental caries in primary and permanent teeth in children and young adults. J Clin Microbiol 2008;46(4):1407–1417. DOI: 10.1128/JCM.01410-07
  4. Araújo IJ, Carvalho MS, Oliveira TR, et al. Antimicrobial activity of mouth rinses against bacteria that initially colonizes dental surface. Rev Odontol UNESP 2019;48:e20180130. DOI: 10.1590/1807-2577.13018
  5. Cieplik F, Jakubovics NS, Buchalla W, et al. Resistance toward chlorhexidine in oral bacteria—is there cause for concern? Front Microbiol 2019;10:587. DOI: 10.3389/fmicb.2019.00587
  6. Philip N, Leishman S, Walsh L. Potential role for natural products in dental caries control. Oral Health Prev Dent 2019;17(5):479–485. DOI: 10.3290/j.ohpd.a42741
  7. Muhammad G, Hussain MA, Jantan I, et al. Mimosa pudica L., a high-value medicinal plant as a source of bioactives for pharmaceuticals. Compr Rev Food Sci Food Saf 2016;15(2):303–315. DOI: 10.1111/1541-4337.12184
  8. Joseph B, George J, Mohan J. Pharmacology and traditional uses of Mimosa pudica. Int J Pharm Sci Drug Res 2013;5(2):41–44.
  9. Joshi K, Joshi AR. Ethnobotanical plants used for dental and oral healthcare in the kali gandaki and bagmati watersheds, Nepal. Ethnobotanical Leaflets 2006;2006(1):18.
  10. Shiloh MU, Ruan J, Nathan C. Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay. Infect Immun 1997;65(8):3193–3198. DOI: 10.1128/iai.65.8.3193-3198.1997
  11. Silverman S Jr, Wilder R. Antimicrobial mouthrinse as part of a comprehensive oral care regimen: safety and compliance factors. J Am Dent Assoc 2006;137 Suppl:S22–S26. DOI: 10.14219/jada.archive.2006.0406
  12. Lemos JA, Palmer SR, Zeng L, et al. The biology of Streptococcus mutans. Microbiol Spectr 2019;7(1):7–10. DOI: 10.1128/microbiolspec.GPP3-0051-2018
  13. Sarker SD, Nahar L, Kumarasamy Y. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 2007;42(4):321–324. DOI: 10.1016/j.ymeth.2007.01.006
  14. Mendoza-Aguilar M, Almaguer-Villagrán L, Jiménez-Arellanes A, et al. The use of the microplate alamar blue assay (MABA) to assess the susceptibility of Mycobacterium lepraemurium to anti-leprosy and other drugs. J Infect Chemother 2012;18(5):652–661. DOI: 10.1007/s10156-012-0387-6
  15. Reichhardt C, Parsek MR. Confocal laser scanning microscopy for analysis of Pseudomonas aeruginosa biofilm architecture and matrix localization. Front Microbiol 2019;10:677. DOI: 10.3389/fmicb.2019.00677
  16. Brookes ZL, Bescos R, Belfield LA, et al. Current uses of chlorhexidine for management of oral disease: a narrative review. J Dent 2020;103:103497. DOI: 10.1016/j.jdent.2020.103497
  17. Cousido MC, Carmona IT, García-Caballero L, et al. In vivo substantivity of 0.12% and 0.2% chlorhexidine mouth rinses on salivary bacteria. Clin Oral Investig 2010;14(4):397–402. DOI: 10.1007/s00784-009-0320-2
  18. Berchier CE, Slot DE, Van der Weijden GA. The efficacy of 0.12% chlorhexidine mouthrinse compared with 0.2% on plaque accumulation and periodontal parameters: a systematic review. J Clin Periodontol 2010;37(9):829–839. DOI: 10.1111/j.1600-051X.2010.01575.x
  19. García-Caballero L, Quintas V, Prada-López I, et al. Chlorhexidine substantivity on salivary flora and plaque-like biofilm: an in situ model. PLoS One 2013;8(12):e83522. DOI: 10.1371/journal.pone.0083522
  20. Shen Y, Stojicic S, Haapasalo M. Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development. J Endod 2011;37(5):657–661. DOI: 10.1016/j.joen.2011.02.007
  21. Seema M. Isolation, characterization and evaluation of Mimosa pudica seed mucilage as pharmaceutical additives. Asian J Pharm 2019;13(4):334–339. DOI: 10.22377/ajp.v13i04.3406
  22. Vijaya Ramu D, Giridhar P, Ravishankar GA. Antimicrobial activity of Mimosa pudica. Asian J Microbiol Biotechnol Environ Sci 2004;6(4):551–552. DOI:
  23. Banu N, Pavithra S. A review on the bioactivity of various metallochlorophyllin—a chlorophyll derivative. Res J Pharm Technol 2017;10(2):480–486. DOI: 10.5958/0974-360X.2017.00096.8
  24. Tungmunnithum D, Thongboonyou A, Pholboon A, et al. Flavonoids and other phenolic compounds from medicinal plants for pharmaceutical and medical aspects: an overview. Medicines (Basel) 2018;5(3):93. DOI: 10.3390/medicines5030093
  25. Erikania S, Raising R. Comparison of tooth paste gel antibacterial activity of ethanol extract and ethyl acetate Mimosa pudica folium against bacteria Streptococcus mutans caries dental disease. Aloha Int J Health Adv 2019;2(7):153–157. DOI: 10.33846/aijha20701
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.